Format
Sort by
Items per page

Send to

Choose Destination

Best matches for polycystic ovary syndrome AND (free full text[sb] AND:

Polycystic ovary syndrome: current status and future perspective. Barthelmess EK et al. Front Biosci (Elite Ed). (2014)

The pathogenesis and treatment of polycystic ovary syndrome: What's new? Bednarska S et al. Adv Clin Exp Med. (2017)

Diagnosis and Treatment of Polycystic Ovary Syndrome. Williams T et al. Am Fam Physician. (2016)

Search results

Items: 1 to 20 of 3373

  • The following terms were ignored: (, AND
  • See the search details.
1.

Association of vitamin D receptor gene variants with polycystic ovary syndrome: a meta-analysis.

Shi XY, Huang AP, Xie DW, Yu XL.

BMC Med Genet. 2019 Feb 14;20(1):32. doi: 10.1186/s12881-019-0763-5.

2.

Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus.

Rodgers R, Avery J, Moore V, Davies M, Azziz R, Stener-Victorin E, Moran L, Robertson S, Stepto N, Norman R, Teede HJ.

Endocr Connect. 2019 Feb 1. pii: EC-18-0502.R2. doi: 10.1530/EC-18-0502. [Epub ahead of print] Review.

3.

Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS).

Januszewski M, Issat T, Jakimiuk AA, Santor-Zaczynska M, Jakimiuk AJ.

Ginekol Pol. 2019;90(1):7-10. doi: 10.5603/GP.2019.0002.

4.

An Unusual Presentation of Deep Vein Thrombosis.

Liyanage AM, Shafiq T, Wadekar VR, Sultan N, Abdulla F.

Eur J Case Rep Intern Med. 2018 Aug 28;5(8):000899. doi: 10.12890/2018_000899. eCollection 2018.

5.

Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis.

Kite C, Lahart IM, Afzal I, Broom DR, Randeva H, Kyrou I, Brown JE.

Syst Rev. 2019 Feb 12;8(1):51. doi: 10.1186/s13643-019-0962-3.

6.

A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics.

O'Reilly MW, Westgate CS, Hornby C, Botfield H, Taylor AE, Markey K, Mitchell JL, Scotton WJ, Mollan SP, Yiangou A, Jenkinson C, Gilligan LC, Sherlock M, Gibney J, Tomlinson JW, Lavery GG, Hodson DJ, Arlt W, Sinclair AJ.

JCI Insight. 2019 Feb 12. pii: 125348. doi: 10.1172/jci.insight.125348. [Epub ahead of print]

7.
8.

Syzygium cumini (L.) Skeels improves metabolic and ovarian parameters in female obese rats with malfunctioning hypothalamus-pituitary-gonadal axis.

Benevides ROA, Vale CC, Fontelles JLL, França LM, Teófilo TS, Silva SN, Paes AMA, Gaspar RS.

J Ovarian Res. 2019 Feb 4;12(1):13. doi: 10.1186/s13048-019-0490-8.

9.

Live birth rates with a freeze-only strategy versus fresh embryo transfer: secondary analysis of a randomized clinical trial.

Vuong LN, Pham TD, Dang VQ, Ho TM, Ho VNA, Norman RJ, Mol BW.

Reprod Biomed Online. 2018 Dec 21. pii: S1472-6483(18)30640-0. doi: 10.1016/j.rbmo.2018.12.012. [Epub ahead of print]

10.

The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Yang S, Gu YY, Jing F, Yu CX, Guan QB.

Med Sci Monit. 2019 Jan 20;25:590-597. doi: 10.12659/MSM.914128.

11.

The Association of Polycystic Ovary Syndrome and Gestational Hypertensive Disorders in a Diverse Community-Based Cohort.

Schneider D, Gonzalez JR, Yamamoto M, Yang J, Lo JC.

J Pregnancy. 2019 Jan 1;2019:9847057. doi: 10.1155/2019/9847057. eCollection 2019.

12.

Association Between Vitamin D Receptor Gene Polymorphisms and Polycystic Ovary Syndrome Risk: A Meta-Analysis.

Niu YM, Wang YD, Jiang GB, Bai G, Chai HB, Li XF, Hu YY, Shen M.

Front Physiol. 2019 Jan 10;9:1902. doi: 10.3389/fphys.2018.01902. eCollection 2018.

13.

Global obesity research trends during 1999 to 2017: A bibliometric analysis.

Zhao N, Tao K, Wang G, Xia Z.

Medicine (Baltimore). 2019 Jan;98(4):e14132. doi: 10.1097/MD.0000000000014132.

14.

Major determinants of circulating myostatin in polycystic ovary syndrome.

Arpaci H.

Exp Ther Med. 2019 Feb;17(2):1383-1389. doi: 10.3892/etm.2018.7080. Epub 2018 Dec 10.

15.

Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.

Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z.

J Ovarian Res. 2019 Jan 21;12(1):5. doi: 10.1186/s13048-019-0480-x.

16.

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.

Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T.

Nutrients. 2019 Jan 17;11(1). pii: E188. doi: 10.3390/nu11010188.

17.

Bisphenol A levels are inversely associated with serum vitamin D-binding protein and sex hormone-binding globulin levels in women with polycystic ovary syndrome: a pilot study.

Jędrzejuk D, Kuliczkowska-Płaksej J, Milewicz A, Wilczewska K, Namieśnik J, Rutkowska A.

Pol Arch Intern Med. 2019 Jan 16. doi: 10.20452/pamw.4419. [Epub ahead of print] No abstract available.

18.

The Relation Between Free Testosterone and Components of Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

Abbasi-Ranjbar Z, Sharami SH, Kazemi S, Sayyad-Abdi D, Dalil Heirati SF.

J Family Reprod Health. 2018 Mar;12(1):1-7.

19.

Antioxidant effects of calligonum extract on ovarian tissue of PCO model: An experimental study.

Tahmasebi F, Movahedin M, Mazaheri Z.

Int J Reprod Biomed (Yazd). 2018 Oct;16(10):641-648.

20.

Body fat percentage is a better marker than body mass index for determining inflammation status in polycystic ovary syndrome.

Hestiantoro A, Kapnosa Hasani RD, Shadrina A, Situmorang H, Ilma N, Muharam R, Sumapraja K, Wiweko B.

Int J Reprod Biomed (Yazd). 2018 Oct;16(10):623-628.

Supplemental Content

Loading ...
Support Center